Research Publications

Our Numbers

500+

Publications

49,600+

Total Times Cited

12,119

Most Times Cited

12+ Mil.

number of single cells analyzed

620 TB

of data generated

10.000+

Yearly Patient Screens

Publication List

Zhang Y, Liang R, Chen C-W, Mallano T, Dees C, Distler A, Reich A, Bergmann C, Ramming A, Gelse K, Milenz D, Distler O,Schett G, Distler JH. JAK1-dependent transphosphorylation of JAK2 limits the anti-fibrotic effects of selective JAK2 inhibitors upon long-term treatment. Ann Rheum Dis. 2017 Aug;76(8):1467-1475.

Moritz F, Schniering J, Distler JHW, Gay RE, Gay S, Distler O, Maurer B. Tie2 as a novel key factor of microangiopathy in systemic sclerosis. Arthritis Res Ther. 2017 May 25;19(1):105.

Zhang Y, Liang R, Chen C-W, Mallano T, Dees C, Distler A, Reich A, Bergmann C, Ramming A, Gelse K, Milenz D, Distler O,Schett G, Distler JH. JAK1-dependent transphosphorylation of JAK2 limits the anti-fibrotic effects of selective JAK2 inhibitors upon long-term treatment. Ann Rheum Dis., 2017 May 6.

Maier C, Ramming A, Bergmann C, Weinkam R, Kittan N, Schett G, Distler JH, Beyer C. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. Ann Rheum Dis. 2017 Feb 16.

Page 1 of 1